hydroxyproline has been researched along with cilomilast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Q; Kobayashi, T; Kohyama, T; Liu, X; Rennard, SI; Wang, HJ; Wen, FQ; Zhu, YK | 1 |
1 other study(ies) available for hydroxyproline and cilomilast
| Article | Year |
|---|---|
Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blotting, Western; Bronchodilator Agents; Carboxylic Acids; Cells, Cultured; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Fibroblasts; Humans; Hydroxyproline; Leukocyte Elastase; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nitriles; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2002 |